Abstract

Introduction

This meta-analysis study assessed the effects of Berberis vulgaris L. and Berberis aristata L. in patients with metabolic syndrome

Methods

Data were analysed through “random-effects meta-regression” performance

Results

The findings indicated that LDL was 0.68 and 2.92 lower in the B. vulgaris L. and B. aristata L.-treated groups versus the controls. The HDL was 0.71-fold higher in the B. aristata L.-treated group versus the controls. The total-cholesterol levels were 1.02 and 2.25 folds lower in the B. vulgaris L. and B. aristata L.-treated groups versus the matched control groups. The triglyceride levels were 1.35 and 1.16-fold lower in the B. vulgaris L. and B. aristata L.-treated groups versus the controls. Glucose was 0.96 and 0.54 folds lower in the B. vulgaris L. and B. aristata L.-treated groups versus the control groups, respectively

Conclusion

B. vulgaris L. and B. aristata L. have beneficial effects in patients with metabolic syndrome.

中文翻译：

---

Berberis vulgaris L. 和 Berberis aristata L. 对代谢综合征患者的影响：一项系统的荟萃分析研究

摘要

介绍

这项荟萃分析研究评估了小檗和小檗对代谢综合征患者的影响

方法

通过“随机效应元回归”性能分析数据

结果

研究结果表明，与对照组相比， B. vulgaris L. 和B. aristata L. 治疗组的LDL 分别低 0.68 和 2.92 。B. aristata L. 治疗组的 HDL 比对照组高 0.71 倍。B. vulgaris L. 和B. aristata L. 治疗组的总胆固醇水平比匹配的对照组低 1.02 倍和 2.25 倍。B. vulgaris L. 和B. aristata L. 治疗组的甘油三酯水平比对照组低 1.35 和 1.16 倍。B. vulgaris L. 和B. aristata中的葡萄糖分别低 0.96 和 0.54 倍L.-治疗组分别与对照组

结论

B. vulgaris L. 和B. aristata L. 对代谢综合征患者有益。